New drugs in respiratory disorders: I.

New drugs in respiratory disorders.

AlthoLgh drugs play a major part in the treatment of respiratory disease, relatively few new ones have been developed in the last few years. Considerable advances, however, have been made in the use of existing agents, particularly bronchodilators and oxygen, and these are discussed in the first of these two articles. As infection is a major cause of respiratory disease the newer antimicrobial ...

NEW DRUGS NEW DRUGS First-in-Class Antibiotic for Respiratory Infections

NEW DRUGS First-in-Class Antibiotic for Respiratory Infections The U.S. Food and Drug Administration (FDA) has approved telithromycin tablets (KetekTM, Aventis) in the U.S. to treat acute exacerbation of chronic bronchitis, acute bacterial sinusitis, and mildto-moderate community-acquired pneumonia, including infections caused by multidrug-resistant Streptococcus pneumoniae, in patients aged 18...

New antiepileptic drugs--I. Basic characteristics.

Respiratory disorders associated with stroke and the role of physiotherapy in the treatment of these disorders

Introduction Stroke is a common neurological disease that can have a negative effect on all parts of the body. The respiratory system is one of the parts of the body that may be damaged by stroke. The respiratory disorders caused by stroke can occur in all three sections of the breath; including metabolic respiration, behavioral respiration and emotional respiration. Disorder in each of these ...

medicinal plants as potential new target drugs in endocrine disorders- review article

noncommunicable diseases pose a real threat to and their incidence is forecast to increase in both developed and developing countries; and, diabetes, obesity, and related complications are predicted to pose a great burden on health care systems all across the world. however, current used conventional medications and surgical interventions fall short of effectively controlling the rampant spread...